Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism.
Peterson SM, Juliana CA, Hu CF, Chai J, Holliday C, Chan KY, Lujan Hernandez AG, Challocombe Z, Wang L, Han Z, Haas N, Stafford R, Axelrod F, Yuan TZ, De León DD, Sato AK.
Peterson SM, et al. Among authors: hu cf.
Diabetes. 2023 Sep 1;72(9):1320-1329. doi: 10.2337/db22-1039.
Diabetes. 2023.
PMID: 37358194
Free PMC article.